» Articles » PMID: 8796243

Tuberculosis in Siberia: 2. Diagnosis, Chemoprophylaxis and Treatment

Overview
Journal Tuber Lung Dis
Specialty Pulmonary Medicine
Date 1996 Aug 1
PMID 8796243
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To assess tuberculosis diagnosis, chemoprophylaxis and therapy in Siberia as a paradigm for the Russian Federation.

Design: Data was obtained from official sources and through visits to dispensaries and hospitals in 1994.

Results: Tuberculosis disease and cure is classified according to a Dispensary Group Register based principally on clinical and radiological criteria. Isoniazid is widely used for chemoprophylaxis and post-therapy and may be linked to high levels of isoniazid resistance. Combination drug therapy is individualized, frequently changed, and given orally, parenterally or intra-bronchially. Galvanization, autotransfusion of ultra-violet irradiated blood, antioxidants and steroids are used as adjunct treatment. Ambulatory treatment is uncommon. Surgical treatments including lobectomy and pneumonectomy are used in 5-10% of patients.

Conclusion: Tuberculosis is increasing in Siberia. An improved drug supply using short course standardized regimens is required supported by high quality co-ordinated bacteriological services. Surgery retains a useful role, but many adjunct therapies should be abandoned.

Citing Articles

Rates of latent tuberculosis in health care staff in Russia.

Drobniewski F, Balabanova Y, Zakamova E, Nikolayevskyy V, Fedorin I PLoS Med. 2007; 4(2):e55.

PMID: 17298167 PMC: 1796908. DOI: 10.1371/journal.pmed.0040055.


Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance.

Cox H, Kebede Y, Allamuratova S, Ismailov G, Davletmuratova Z, Byrnes G PLoS Med. 2006; 3(10):e384.

PMID: 17020405 PMC: 1584414. DOI: 10.1371/journal.pmed.0030384.


Variability in interpretation of chest radiographs among Russian clinicians and implications for screening programmes: observational study.

Balabanova Y, Coker R, Fedorin I, Zakharova S, Plavinskij S, Krukov N BMJ. 2005; 331(7513):379-82.

PMID: 16096305 PMC: 1184248. DOI: 10.1136/bmj.331.7513.379.


Kanamycin susceptibility testing of Mycobacterium tuberculosis using Mycobacterium Growth Indicator Tube and a colorimetric method.

Bastian I, Rigouts L, Palomino J, Portaels F Antimicrob Agents Chemother. 2001; 45(6):1934-6.

PMID: 11353658 PMC: 90578. DOI: 10.1128/AAC.45.6.1934-1936.2001.


Survey of drug-resistant tuberculosis in northwestern Russia from 1984 through 1994.

Viljanen M, Vyshnevskiy B, Otten T, Vyshnevskaya E, Marjamaki M, Soini H Eur J Clin Microbiol Infect Dis. 1998; 17(3):177-83.

PMID: 9665299 DOI: 10.1007/BF01691114.